Analysts think SNOA stock price could increase by 850%
Sep 26, 2024, 11:26 AM
-7.14%
What does SNOA do
Sonoma Pharmaceuticals, headquartered in Boulder, Colorado, develops hypochlorous acid products for various healthcare applications and went public on January 26, 2007. Their product lineup includes Lumacyn, Regenacyn, and MicrocynAH for skin and wound care.
3 analysts think SNOA stock price will increase by 850.31%. The current median analyst target is $30.60 compared to a current stock price of $3.22. The lowest analysts target is $30.30 and the highest analyst target is $31.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
